Prescription Dermatological Drugs Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0063947
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:6.02
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 6.02 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
In 2018, the global Prescription Dermatological Drugs market size was million US$ and it is expected to reach million US$ by the end of 2026, with a CAGR of during 2019-2026.This report focuses on the global Prescription Dermatological Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prescription Dermatological Drugs development in United States, Europe and China.
The key players covered in this study
Johnson & Johnson
Merck
Bayer
Mylan Pharmaceuticals
Pfizer
F. Hoffmann-La Roche
Allergan
Valeant Pharmaceuticals
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation
Market segment by Type, the product can be split into
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Prescription Dermatological Drugs status, future forecast, growth opportunity, key market and key players.
To present the Prescription Dermatological Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Prescription Dermatological Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type (2014-2026)
1.4.2 Anti-acne Drugs
1.4.3 Anti-aging Drugs
1.4.4 Dermatitis Drugs
1.4.5 Hair Loss Drugs
1.4.6 Psoriasis Drugs
1.4.7 Skin Cancer Drugs
1.4.8 Melasma Drugs
1.4.9 Seborrhea Drugs
1.5 Market by Application
1.5.1 Global Prescription Dermatological Drugs Market Share by Application (2014-2026)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Prescription Dermatological Drugs Market Size
2.2 Prescription Dermatological Drugs Growth Trends by Regions
2.2.1 Prescription Dermatological Drugs Market Size by Regions (2014-2026)
2.2.2 Prescription Dermatological Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Prescription Dermatological Drugs Market Size by Manufacturers
3.1.1 Global Prescription Dermatological Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Prescription Dermatological Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prescription Dermatological Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Prescription Dermatological Drugs Key Players Head office and Area Served
3.3 Key Players Prescription Dermatological Drugs Product/Solution/Service
3.4 Date of Enter into Prescription Dermatological Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Prescription Dermatological Drugs Market Size by Type (2014-2019)
4.2 Global Prescription Dermatological Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Prescription Dermatological Drugs Market Size (2014-2019)
5.2 Prescription Dermatological Drugs Key Players in United States
5.3 United States Prescription Dermatological Drugs Market Size by Type
5.4 United States Prescription Dermatological Drugs Market Size by Application
6 Europe
6.1 Europe Prescription Dermatological Drugs Market Size (2014-2019)
6.2 Prescription Dermatological Drugs Key Players in Europe
6.3 Europe Prescription Dermatological Drugs Market Size by Type
6.4 Europe Prescription Dermatological Drugs Market Size by Application
7 China
7.1 China Prescription Dermatological Drugs Market Size (2014-2019)
7.2 Prescription Dermatological Drugs Key Players in China
7.3 China Prescription Dermatological Drugs Market Size by Type
7.4 China Prescription Dermatological Drugs Market Size by Application
8 Japan
8.1 Japan Prescription Dermatological Drugs Market Size (2014-2019)
8.2 Prescription Dermatological Drugs Key Players in Japan
8.3 Japan Prescription Dermatological Drugs Market Size by Type
8.4 Japan Prescription Dermatological Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Prescription Dermatological Drugs Market Size (2014-2019)
9.2 Prescription Dermatological Drugs Key Players in Southeast Asia
9.3 Southeast Asia Prescription Dermatological Drugs Market Size by Type
9.4 Southeast Asia Prescription Dermatological Drugs Market Size by Application
10 India
10.1 India Prescription Dermatological Drugs Market Size (2014-2019)
10.2 Prescription Dermatological Drugs Key Players in India
10.3 India Prescription Dermatological Drugs Market Size by Type
10.4 India Prescription Dermatological Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Prescription Dermatological Drugs Market Size (2014-2019)
11.2 Prescription Dermatological Drugs Key Players in Central & South America
11.3 Central & South America Prescription Dermatological Drugs Market Size by Type
11.4 Central & South America Prescription Dermatological Drugs Market Size by Application
12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prescription Dermatological Drugs Introduction
12.1.4 Johnson & Johnson Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prescription Dermatological Drugs Introduction
12.2.4 Merck Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prescription Dermatological Drugs Introduction
12.3.4 Bayer Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Mylan Pharmaceuticals
12.4.1 Mylan Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prescription Dermatological Drugs Introduction
12.4.4 Mylan Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.4.5 Mylan Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prescription Dermatological Drugs Introduction
12.5.4 Pfizer Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 F. Hoffmann-La Roche
12.6.1 F. Hoffmann-La Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prescription Dermatological Drugs Introduction
12.6.4 F. Hoffmann-La Roche Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.6.5 F. Hoffmann-La Roche Recent Development
12.7 Allergan
12.7.1 Allergan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prescription Dermatological Drugs Introduction
12.7.4 Allergan Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.7.5 Allergan Recent Development
12.8 Valeant Pharmaceuticals
12.8.1 Valeant Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prescription Dermatological Drugs Introduction
12.8.4 Valeant Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.8.5 Valeant Pharmaceuticals Recent Development
12.9 PharmaDerm Pharmaceuticals
12.9.1 PharmaDerm Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prescription Dermatological Drugs Introduction
12.9.4 PharmaDerm Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.9.5 PharmaDerm Pharmaceuticals Recent Development
12.10 Allergan Inamed Corporation
12.10.1 Allergan Inamed Corporation Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prescription Dermatological Drugs Introduction
12.10.4 Allergan Inamed Corporation Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.10.5 Allergan Inamed Corporation Recent Development
13 Market Forecast 2019-2026
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2026)
13.10 Market Size Forecast by Application (2019-2026)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Prescription Dermatological Drugs Key Market Segments
Table Key Players Prescription Dermatological Drugs Covered
Table Global Prescription Dermatological Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Prescription Dermatological Drugs Market Size Market Share by Type 2014-2025
Figure Anti-acne Drugs Figures
Table Key Players of Anti-acne Drugs
Figure Anti-aging Drugs Figures
Table Key Players of Anti-aging Drugs
Figure Dermatitis Drugs Figures
Table Key Players of Dermatitis Drugs
Figure Hair Loss Drugs Figures
Table Key Players of Hair Loss Drugs
Figure Psoriasis Drugs Figures
Table Key Players of Psoriasis Drugs
Figure Skin Cancer Drugs Figures
Table Key Players of Skin Cancer Drugs
Figure Melasma Drugs Figures
Table Key Players of Melasma Drugs
Figure Seborrhea Drugs Figures
Table Key Players of Seborrhea Drugs
Table Global Prescription Dermatological Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Prescription Dermatological Drugs Report Years Considered
Table Global Prescription Dermatological Drugs Market Size 2014-2025 (Million US$)
Figure Global Prescription Dermatological Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Prescription Dermatological Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Prescription Dermatological Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Prescription Dermatological Drugs Market Share by Regions 2014-2019
Figure Global Prescription Dermatological Drugs Market Share by Regions 2014-2019
Figure Global Prescription Dermatological Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Prescription Dermatological Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Prescription Dermatological Drugs Market Share by Manufacturers (2014-2019)
Figure Global Prescription Dermatological Drugs Market Share by Manufacturers in 2018
Table Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Prescription Dermatological Drugs Product/Solution/Service
Table Date of Enter into Prescription Dermatological Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Prescription Dermatological Drugs Market Size Share by Type (2014-2019)
Figure Global Prescription Dermatological Drugs Market Size Market Share by Type (2014-2019)
Table Global Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Prescription Dermatological Drugs Market Size Share by Application (2014-2019)
Figure Global Prescription Dermatological Drugs Market Size Market Share by Application (2014-2019)
Figure Global Prescription Dermatological Drugs Revenue Market Share by Application in 2018
Figure United States Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table United States Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table United States Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure Europe Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table Europe Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table Europe Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure China Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table China Prescription Dermatological Drugs Market Size by Type (2014-20189) (Million US$)
Table China Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table China Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table China Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure Japan Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table Japan Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table Japan Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table Southeast Asia Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table Southeast Asia Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure India Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table India Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table India Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table India Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table India Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure Central & South America Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table Central & South America Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table Central & South America Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Prescription Dermatological Drugs Market Share by Application (2014-2019)
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Prescription Dermatological Drugs Business (2014-2019) (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Merck Recent Development
Table Bayer Company Details
Table Bayer Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Bayer Recent Development
Table Mylan Pharmaceuticals Company Details
Table Mylan Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Mylan Pharmaceuticals Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Mylan Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Pfizer Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Allergan Company Details
Table Allergan Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Allergan Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table PharmaDerm Pharmaceuticals Company Details
Table PharmaDerm Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure PharmaDerm Pharmaceuticals Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table PharmaDerm Pharmaceuticals Recent Development
Table Allergan Inamed Corporation Company Details
Table Allergan Inamed Corporation Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Allergan Inamed Corporation Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Allergan Inamed Corporation Recent Development
Table Global Prescription Dermatological Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Prescription Dermatological Drugs Market Size Share by Regions (2019-2025)
Figure Global Prescription Dermatological Drugs Market Size Share by Regions in 2025
Figure United States Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Prescription Dermatological Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Prescription Dermatological Drugs Market Size by Product (2019-2025)
Figure Global Prescription Dermatological Drugs Market Size by Product in 2025
Table Global Prescription Dermatological Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Prescription Dermatological Drugs Market Size by Application (2019-2025)
Figure Global Prescription Dermatological Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type (2014-2026)
1.4.2 Anti-acne Drugs
1.4.3 Anti-aging Drugs
1.4.4 Dermatitis Drugs
1.4.5 Hair Loss Drugs
1.4.6 Psoriasis Drugs
1.4.7 Skin Cancer Drugs
1.4.8 Melasma Drugs
1.4.9 Seborrhea Drugs
1.5 Market by Application
1.5.1 Global Prescription Dermatological Drugs Market Share by Application (2014-2026)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Prescription Dermatological Drugs Market Size
2.2 Prescription Dermatological Drugs Growth Trends by Regions
2.2.1 Prescription Dermatological Drugs Market Size by Regions (2014-2026)
2.2.2 Prescription Dermatological Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Prescription Dermatological Drugs Market Size by Manufacturers
3.1.1 Global Prescription Dermatological Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Prescription Dermatological Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prescription Dermatological Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Prescription Dermatological Drugs Key Players Head office and Area Served
3.3 Key Players Prescription Dermatological Drugs Product/Solution/Service
3.4 Date of Enter into Prescription Dermatological Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Prescription Dermatological Drugs Market Size by Type (2014-2019)
4.2 Global Prescription Dermatological Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Prescription Dermatological Drugs Market Size (2014-2019)
5.2 Prescription Dermatological Drugs Key Players in United States
5.3 United States Prescription Dermatological Drugs Market Size by Type
5.4 United States Prescription Dermatological Drugs Market Size by Application
6 Europe
6.1 Europe Prescription Dermatological Drugs Market Size (2014-2019)
6.2 Prescription Dermatological Drugs Key Players in Europe
6.3 Europe Prescription Dermatological Drugs Market Size by Type
6.4 Europe Prescription Dermatological Drugs Market Size by Application
7 China
7.1 China Prescription Dermatological Drugs Market Size (2014-2019)
7.2 Prescription Dermatological Drugs Key Players in China
7.3 China Prescription Dermatological Drugs Market Size by Type
7.4 China Prescription Dermatological Drugs Market Size by Application
8 Japan
8.1 Japan Prescription Dermatological Drugs Market Size (2014-2019)
8.2 Prescription Dermatological Drugs Key Players in Japan
8.3 Japan Prescription Dermatological Drugs Market Size by Type
8.4 Japan Prescription Dermatological Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Prescription Dermatological Drugs Market Size (2014-2019)
9.2 Prescription Dermatological Drugs Key Players in Southeast Asia
9.3 Southeast Asia Prescription Dermatological Drugs Market Size by Type
9.4 Southeast Asia Prescription Dermatological Drugs Market Size by Application
10 India
10.1 India Prescription Dermatological Drugs Market Size (2014-2019)
10.2 Prescription Dermatological Drugs Key Players in India
10.3 India Prescription Dermatological Drugs Market Size by Type
10.4 India Prescription Dermatological Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Prescription Dermatological Drugs Market Size (2014-2019)
11.2 Prescription Dermatological Drugs Key Players in Central & South America
11.3 Central & South America Prescription Dermatological Drugs Market Size by Type
11.4 Central & South America Prescription Dermatological Drugs Market Size by Application
12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prescription Dermatological Drugs Introduction
12.1.4 Johnson & Johnson Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prescription Dermatological Drugs Introduction
12.2.4 Merck Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prescription Dermatological Drugs Introduction
12.3.4 Bayer Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Mylan Pharmaceuticals
12.4.1 Mylan Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prescription Dermatological Drugs Introduction
12.4.4 Mylan Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.4.5 Mylan Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prescription Dermatological Drugs Introduction
12.5.4 Pfizer Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 F. Hoffmann-La Roche
12.6.1 F. Hoffmann-La Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prescription Dermatological Drugs Introduction
12.6.4 F. Hoffmann-La Roche Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.6.5 F. Hoffmann-La Roche Recent Development
12.7 Allergan
12.7.1 Allergan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prescription Dermatological Drugs Introduction
12.7.4 Allergan Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.7.5 Allergan Recent Development
12.8 Valeant Pharmaceuticals
12.8.1 Valeant Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prescription Dermatological Drugs Introduction
12.8.4 Valeant Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.8.5 Valeant Pharmaceuticals Recent Development
12.9 PharmaDerm Pharmaceuticals
12.9.1 PharmaDerm Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prescription Dermatological Drugs Introduction
12.9.4 PharmaDerm Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.9.5 PharmaDerm Pharmaceuticals Recent Development
12.10 Allergan Inamed Corporation
12.10.1 Allergan Inamed Corporation Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prescription Dermatological Drugs Introduction
12.10.4 Allergan Inamed Corporation Revenue in Prescription Dermatological Drugs Business (2014-2019)
12.10.5 Allergan Inamed Corporation Recent Development
13 Market Forecast 2019-2026
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2026)
13.10 Market Size Forecast by Application (2019-2026)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Prescription Dermatological Drugs Key Market Segments
Table Key Players Prescription Dermatological Drugs Covered
Table Global Prescription Dermatological Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Prescription Dermatological Drugs Market Size Market Share by Type 2014-2025
Figure Anti-acne Drugs Figures
Table Key Players of Anti-acne Drugs
Figure Anti-aging Drugs Figures
Table Key Players of Anti-aging Drugs
Figure Dermatitis Drugs Figures
Table Key Players of Dermatitis Drugs
Figure Hair Loss Drugs Figures
Table Key Players of Hair Loss Drugs
Figure Psoriasis Drugs Figures
Table Key Players of Psoriasis Drugs
Figure Skin Cancer Drugs Figures
Table Key Players of Skin Cancer Drugs
Figure Melasma Drugs Figures
Table Key Players of Melasma Drugs
Figure Seborrhea Drugs Figures
Table Key Players of Seborrhea Drugs
Table Global Prescription Dermatological Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Prescription Dermatological Drugs Report Years Considered
Table Global Prescription Dermatological Drugs Market Size 2014-2025 (Million US$)
Figure Global Prescription Dermatological Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Prescription Dermatological Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Prescription Dermatological Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Prescription Dermatological Drugs Market Share by Regions 2014-2019
Figure Global Prescription Dermatological Drugs Market Share by Regions 2014-2019
Figure Global Prescription Dermatological Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Prescription Dermatological Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Prescription Dermatological Drugs Market Share by Manufacturers (2014-2019)
Figure Global Prescription Dermatological Drugs Market Share by Manufacturers in 2018
Table Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Prescription Dermatological Drugs Product/Solution/Service
Table Date of Enter into Prescription Dermatological Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Prescription Dermatological Drugs Market Size Share by Type (2014-2019)
Figure Global Prescription Dermatological Drugs Market Size Market Share by Type (2014-2019)
Table Global Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Prescription Dermatological Drugs Market Size Share by Application (2014-2019)
Figure Global Prescription Dermatological Drugs Market Size Market Share by Application (2014-2019)
Figure Global Prescription Dermatological Drugs Revenue Market Share by Application in 2018
Figure United States Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table United States Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table United States Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure Europe Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table Europe Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table Europe Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure China Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table China Prescription Dermatological Drugs Market Size by Type (2014-20189) (Million US$)
Table China Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table China Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table China Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure Japan Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table Japan Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table Japan Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table Southeast Asia Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table Southeast Asia Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure India Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table India Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table India Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table India Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table India Prescription Dermatological Drugs Market Share by Application (2014-2019)
Figure Central & South America Prescription Dermatological Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Prescription Dermatological Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Prescription Dermatological Drugs Market Share (2018-2019)
Table Central & South America Prescription Dermatological Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Prescription Dermatological Drugs Market Share by Type (2014-2019)
Table Central & South America Prescription Dermatological Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Prescription Dermatological Drugs Market Share by Application (2014-2019)
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Prescription Dermatological Drugs Business (2014-2019) (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Merck Recent Development
Table Bayer Company Details
Table Bayer Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Bayer Recent Development
Table Mylan Pharmaceuticals Company Details
Table Mylan Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Mylan Pharmaceuticals Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Mylan Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Pfizer Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Allergan Company Details
Table Allergan Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Allergan Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table PharmaDerm Pharmaceuticals Company Details
Table PharmaDerm Pharmaceuticals Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure PharmaDerm Pharmaceuticals Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table PharmaDerm Pharmaceuticals Recent Development
Table Allergan Inamed Corporation Company Details
Table Allergan Inamed Corporation Revenue in Prescription Dermatological Drugs Business (2014-2019)(Million US$)
Figure Allergan Inamed Corporation Revenue Growth Rate in Prescription Dermatological Drugs Business (2014-2019)
Table Allergan Inamed Corporation Recent Development
Table Global Prescription Dermatological Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Prescription Dermatological Drugs Market Size Share by Regions (2019-2025)
Figure Global Prescription Dermatological Drugs Market Size Share by Regions in 2025
Figure United States Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Prescription Dermatological Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Prescription Dermatological Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Prescription Dermatological Drugs Market Size by Product (2019-2025)
Figure Global Prescription Dermatological Drugs Market Size by Product in 2025
Table Global Prescription Dermatological Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Prescription Dermatological Drugs Market Size by Application (2019-2025)
Figure Global Prescription Dermatological Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"